Endobronchial valves for emphysema without interlobar collateral ventilation

New England Journal of Medicine

Volumn 373, Issue 24, 2015, Pages 2325-2335

  Klooster, Karin ^a   Ten Hacken, Nick H T ^a   Hartman, Jorine E ^a   Kerstjens, Huib A M ^a   Van Rikxoort, Eva M ^b   Slebos, Dirk Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE REMOVAL; DEVICE SAFETY; DISEASE SEVERITY; ENDOBRONCHIAL VALVE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; PNEUMOTHORAX; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY VALVE PROSTHESIS; PULMONARY VALVE REPLACEMENT; TREATMENT OUTCOME; TREATMENT RESPONSE; AGED; BRONCHUS; EXERCISE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTHESES AND ORTHOSES; PULMONARY EMPHYSEMA; RANDOMIZED CONTROLLED TRIAL; VITAL CAPACITY;

AGED; BRONCHI; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; PULMONARY EMPHYSEMA; VITAL CAPACITY;

EID: 84949444006     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1507807     Document Type: Article

References (24)

1. Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363: 1233-44.
2. Herth FJ, Noppen M, Valipour A, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39: 1334-42.
3. Koenigkam-Santos M, Puderbach M, Gompelmann D, et al. Incomplete fissures in severe emphysematous patients evaluated with MDCT: incidence and interobserver agreement among radiologists and pneumologists. Eur J Radiol 2012; 81: 4161-6.
4. Herth FJ, Eberhardt R, Gompelmann D, et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J 2013; 41: 302-8.
5. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-5.
6. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-6.
7. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-7.
8. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005; 2: 75-9.
9. Kocks JW, Tuinenga MG, Uil SM, van den Berg JW, Ståhl E, van der Molen T. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res 2006; 7: 62.
10. Donohue JF. Minimal clinically important differences in COPD lung function. COPD 2005; 2: 111-24.
11. Puhan MA, Chandra D, Mosenifar Z, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011; 37: 784-90.
12. Hartman JE, Ten Hacken NH, Klooster K, Boezen HM, de Greef MH, Slebos DJ. The minimal important difference for residual volume in patients with severe emphysema. Eur Respir J 2012; 40: 1137-41.
13. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-7.
14. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26: 153-61.
15. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
16. van Rikxoort EM, de Hoop B, Viergever MA, Prokop M, van Ginneken B. Automatic lung segmentation from thoracic computed tomography scans using a hybrid approach with error detection. Med Phys 2009; 36: 2934-47.
17. van Rikxoort EM, Prokop M, de Hoop B, Viergever MA, Pluim JP, van Ginneken B. Automatic segmentation of pulmonary lobes robust against incomplete fissures. IEEE Trans Med Imaging 2010; 29: 1286-96.
18. Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361: 931-3.
19. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lungvolume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059-73.
20. Criner GJ, Cordova F, Sternberg AL, Martinez FJ. The National Emphysema Treatment Trial (NETT) Part II: lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med 2011; 184: 881-93.
21. Shah PL, Slebos DJ, Cardoso PF, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet 2011; 378: 997-1005.
22. Valipour A, Slebos DJ, de Oliveira HG, et al. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema - potential mechanisms, treatment algorithm, and case examples. Respiration 2014; 87: 513-21.
23. Gompelmann D, Eberhardt R, Herth F, et al. Endoscopic volume reduction in COPD: a critical review. Dtsch Arztebl Int 2014; 111: 827-33.
24. Gompelmann D, Herth FJ, Slebos DJ, et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration 2014; 87: 485-91.